AAPL355.47-0.80 (-0.22%) ▼|ABBV298.47+3.44 (+1.16%) ▲|ABT108.97+0.45 (+0.41%) ▲|ACN250.94+0.45 (+0.18%) ▲|ADBE249.76+6.68 (+2.75%) ▲|AMAT357.06-13.44 (-3.63%) ▼|AMD514.08-19.98 (-3.74%) ▼|AMGN469.61+3.94 (+0.85%) ▲|AMT191.65+0.01 (+0.01%) ▲|AMZN261.81-4.85 (-1.82%) ▼|AVGO336.56-10.46 (-3.01%) ▼|AXP318.61-1.99 (-0.62%) ▼|BA166.62-4.88 (-2.85%) ▼|BAC50.42-0.61 (-1.19%) ▼|BKNG157.57-2.01 (-1.26%) ▼|BLK1,208.10-14.82 (-1.21%) ▼|BMY62.96-0.47 (-0.74%) ▼|BNY152.29-1.12 (-0.73%) ▼|BRK-B594.03+1.09 (+0.18%) ▲|C122.56-1.45 (-1.17%) ▼|CAT581.84-18.36 (-3.06%) ▼|CL100.92+1.25 (+1.25%) ▲|CMCSA25.64+0.48 (+1.91%) ▲|COF194.07-0.21 (-0.11%) ▼|COP140.98-0.37 (-0.26%) ▼|COST1,110.90+4.69 (+0.42%) ▲|CRM217.57-0.27 (-0.12%) ▼|CSCO94.23-1.41 (-1.47%) ▼|CVS88.66-0.69 (-0.77%) ▼|CVX217.90-1.99 (-0.91%) ▼|DE664.03-9.51 (-1.41%) ▼|DHR231.51-1.52 (-0.65%) ▼|DIS118.64-0.33 (-0.28%) ▼|DUK130.27+1.11 (+0.86%) ▲|EMR161.72-4.66 (-2.80%) ▼|FDX326.59+2.45 (+0.76%) ▲|GD360.89-2.57 (-0.71%) ▼|GE327.64-4.17 (-1.26%) ▼|GEV777.29-25.84 (-3.22%) ▼|GILD169.82+1.74 (+1.04%) ▲|GM84.47-1.53 (-1.78%) ▼|GOOG285.43-7.09 (-2.42%) ▼|GOOGL288.49-7.28 (-2.46%) ▼|GS898.05-18.51 (-2.02%) ▼|HD347.41-1.28 (-0.37%) ▼|HON220.84-1.63 (-0.73%) ▼|IBM245.13-2.01 (-0.81%) ▼|INTC56.11-3.55 (-5.95%) ▼|INTU350.18+8.48 (+2.48%) ▲|ISRG440.38-3.21 (-0.72%) ▼|JNJ285.18-0.57 (-0.20%) ▼|JPM343.24-2.95 (-0.85%) ▼|KO99.60+0.35 (+0.35%) ▲|LIN528.23+2.17 (+0.41%) ▲|LLY1,452.90+9.40 (+0.65%) ▲|LMT584.61-11.44 (-1.92%) ▼|LOW226.47-1.26 (-0.55%) ▼|LRCX216.12-9.80 (-4.34%) ▼|MA665.64+4.45 (+0.67%) ▲|MCD276.17+4.20 (+1.54%) ▲|MDLZ67.79+0.25 (+0.37%) ▲|MDT103.29+0.43 (+0.42%) ▲|META631.34-10.35 (-1.61%) ▼|MMM184.03+0.37 (+0.20%) ▲|MO78.74+0.10 (+0.13%) ▲|MRK147.17-0.59 (-0.40%) ▼|MS186.06-4.60 (-2.41%) ▼|MSFT525.82+1.94 (+0.37%) ▲|MU735.78-42.54 (-5.47%) ▼|NEE85.35+0.23 (+0.26%) ▲|NFLX61.55-0.60 (-0.97%) ▼|NKE38.00+0.01 (+0.03%) ▲|NOW101.47-0.78 (-0.76%) ▼|NVDA159.77-3.08 (-1.89%) ▼|ORCL121.11-4.24 (-3.38%) ▼|PEP146.65+1.21 (+0.83%) ▲|PFE28.98+0.09 (+0.29%) ▲|PG172.38+2.58 (+1.52%) ▲|PLTR164.41-3.58 (-2.13%) ▼|PM196.49-2.47 (-1.24%) ▼|QCOM171.71-0.76 (-0.44%) ▼|RTX196.85-1.73 (-0.87%) ▼|SBUX109.04+2.60 (+2.44%) ▲|SCHW93.70+0.72 (+0.77%) ▲|SO93.79+0.96 (+1.03%) ▲|SPG231.27-1.71 (-0.73%) ▼|T22.46+0.28 (+1.26%) ▲|TMO696.87-3.36 (-0.48%) ▼|TMUS170.36+0.41 (+0.24%) ▲|TSLA381.54-8.69 (-2.23%) ▼|TXN297.84-5.76 (-1.90%) ▼|UBER70.61+0.92 (+1.32%) ▲|UNH410.10+2.64 (+0.65%) ▲|UNP304.55+2.11 (+0.70%) ▲|UPS111.28+0.52 (+0.47%) ▲|USB60.85-0.14 (-0.23%) ▼|V429.29+3.53 (+0.83%) ▲|VZ46.58+0.22 (+0.47%) ▲|WFC85.49-0.56 (-0.65%) ▼|WMT128.18+0.09 (+0.07%) ▲|XOM167.76-1.76 (-1.04%) ▼|AAPL355.47-0.80 (-0.22%) ▼|ABBV298.47+3.44 (+1.16%) ▲|ABT108.97+0.45 (+0.41%) ▲|ACN250.94+0.45 (+0.18%) ▲|ADBE249.76+6.68 (+2.75%) ▲|AMAT357.06-13.44 (-3.63%) ▼|AMD514.08-19.98 (-3.74%) ▼|AMGN469.61+3.94 (+0.85%) ▲|AMT191.65+0.01 (+0.01%) ▲|AMZN261.81-4.85 (-1.82%) ▼|AVGO336.56-10.46 (-3.01%) ▼|AXP318.61-1.99 (-0.62%) ▼|BA166.62-4.88 (-2.85%) ▼|BAC50.42-0.61 (-1.19%) ▼|BKNG157.57-2.01 (-1.26%) ▼|BLK1,208.10-14.82 (-1.21%) ▼|BMY62.96-0.47 (-0.74%) ▼|BNY152.29-1.12 (-0.73%) ▼|BRK-B594.03+1.09 (+0.18%) ▲|C122.56-1.45 (-1.17%) ▼|CAT581.84-18.36 (-3.06%) ▼|CL100.92+1.25 (+1.25%) ▲|CMCSA25.64+0.48 (+1.91%) ▲|COF194.07-0.21 (-0.11%) ▼|COP140.98-0.37 (-0.26%) ▼|COST1,110.90+4.69 (+0.42%) ▲|CRM217.57-0.27 (-0.12%) ▼|CSCO94.23-1.41 (-1.47%) ▼|CVS88.66-0.69 (-0.77%) ▼|CVX217.90-1.99 (-0.91%) ▼|DE664.03-9.51 (-1.41%) ▼|DHR231.51-1.52 (-0.65%) ▼|DIS118.64-0.33 (-0.28%) ▼|DUK130.27+1.11 (+0.86%) ▲|EMR161.72-4.66 (-2.80%) ▼|FDX326.59+2.45 (+0.76%) ▲|GD360.89-2.57 (-0.71%) ▼|GE327.64-4.17 (-1.26%) ▼|GEV777.29-25.84 (-3.22%) ▼|GILD169.82+1.74 (+1.04%) ▲|GM84.47-1.53 (-1.78%) ▼|GOOG285.43-7.09 (-2.42%) ▼|GOOGL288.49-7.28 (-2.46%) ▼|GS898.05-18.51 (-2.02%) ▼|HD347.41-1.28 (-0.37%) ▼|HON220.84-1.63 (-0.73%) ▼|IBM245.13-2.01 (-0.81%) ▼|INTC56.11-3.55 (-5.95%) ▼|INTU350.18+8.48 (+2.48%) ▲|ISRG440.38-3.21 (-0.72%) ▼|JNJ285.18-0.57 (-0.20%) ▼|JPM343.24-2.95 (-0.85%) ▼|KO99.60+0.35 (+0.35%) ▲|LIN528.23+2.17 (+0.41%) ▲|LLY1,452.90+9.40 (+0.65%) ▲|LMT584.61-11.44 (-1.92%) ▼|LOW226.47-1.26 (-0.55%) ▼|LRCX216.12-9.80 (-4.34%) ▼|MA665.64+4.45 (+0.67%) ▲|MCD276.17+4.20 (+1.54%) ▲|MDLZ67.79+0.25 (+0.37%) ▲|MDT103.29+0.43 (+0.42%) ▲|META631.34-10.35 (-1.61%) ▼|MMM184.03+0.37 (+0.20%) ▲|MO78.74+0.10 (+0.13%) ▲|MRK147.17-0.59 (-0.40%) ▼|MS186.06-4.60 (-2.41%) ▼|MSFT525.82+1.94 (+0.37%) ▲|MU735.78-42.54 (-5.47%) ▼|NEE85.35+0.23 (+0.26%) ▲|NFLX61.55-0.60 (-0.97%) ▼|NKE38.00+0.01 (+0.03%) ▲|NOW101.47-0.78 (-0.76%) ▼|NVDA159.77-3.08 (-1.89%) ▼|ORCL121.11-4.24 (-3.38%) ▼|PEP146.65+1.21 (+0.83%) ▲|PFE28.98+0.09 (+0.29%) ▲|PG172.38+2.58 (+1.52%) ▲|PLTR164.41-3.58 (-2.13%) ▼|PM196.49-2.47 (-1.24%) ▼|QCOM171.71-0.76 (-0.44%) ▼|RTX196.85-1.73 (-0.87%) ▼|SBUX109.04+2.60 (+2.44%) ▲|SCHW93.70+0.72 (+0.77%) ▲|SO93.79+0.96 (+1.03%) ▲|SPG231.27-1.71 (-0.73%) ▼|T22.46+0.28 (+1.26%) ▲|TMO696.87-3.36 (-0.48%) ▼|TMUS170.36+0.41 (+0.24%) ▲|TSLA381.54-8.69 (-2.23%) ▼|TXN297.84-5.76 (-1.90%) ▼|UBER70.61+0.92 (+1.32%) ▲|UNH410.10+2.64 (+0.65%) ▲|UNP304.55+2.11 (+0.70%) ▲|UPS111.28+0.52 (+0.47%) ▲|USB60.85-0.14 (-0.23%) ▼|V429.29+3.53 (+0.83%) ▲|VZ46.58+0.22 (+0.47%) ▲|WFC85.49-0.56 (-0.65%) ▼|WMT128.18+0.09 (+0.07%) ▲|XOM167.76-1.76 (-1.04%) ▼|
10 C
New York
Monday, November 16, 2026

Energy

IBM, Fermilab, and NVIDIA Announce Plans for New Co-Design Platform to Accelerate the Development of Next-Generation, Modular Quantum Computers

Researchers plan to use modular quantum computing co-design platform to explore computationally demanding problems in high-energy and nuclear physics. New Slurm® integration simplifies how HPC users can orchestrate and...

Electrical Warning Signs Explained in HelloNation Article Featuring Electrical Expert Gerald Talbot

The article outlines common electrical warning signs that homeowners should treat as potential safety...

Specialty Food Association Unveils 2027 Trends Forecast, Reflecting Growing Consumer Hunger for Realness

Winter FancyFaire* attendees will be able to see these trends in action and get...

LiftMaster Expands MAXUM Commercial Door Operator Line With NEMA 4X Protection

Watertight, corrosion-resistant operators extend MAXUM performance to car washes, agricultural facilities and coastal sitesOAK...

Skyhawk Therapeutics Announces First U.S. Patients Dosed in Pivotal FALCON-HD Study Evaluating SKY-0515 in Huntington’s Disease

More than 50,000 doses of SKY-0515 have now been administered to patients.BOSTON, Nov. 5, 2026 /PRNewswire/ -- Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company...

PJM Winter Outlook: Power Supplies Available to Serve Expected Cold Weather Conditions

Generation Resource Performance Critical to Maintaining ReliabilityVALLEY FORGE, Pa., Nov. 5, 2026 /PRNewswire/ -- PJM expects to have sufficient resources to reliably meet electricity...

ImmunoGenesis Announces Two Publications Highlighting the Potential of IMGS-203, a Novel Stimulator of Interferon Genes (STING) Agonist, to Overcome Tumor Immune Resistance and Enhance...

HOUSTON, Nov. 5, 2026 /PRNewswire/ -- ImmunoGenesis, a clinical-stage biotech company developing innovative, science-driven immunotherapies, today announced two publications providing new nonclinical evidence and...

/C O R R E C T I O N – Roundtable On Sustainable Palm Oil/

In the news release, RSPO RT2026 Addresses Indonesia Fires, Single Export Gate, and Smallholder Inclusion, issued 04-Nov-2026 by Roundtable On Sustainable Palm Oil over...

Arcadis selected to provide construction management for the Friant-Kern Canal Middle Reach Capacity Correction project

Major infrastructure project will restore critical water capacity in California's Central Valley.FRESNO, Calif., Nov. 5, 2026 /PRNewswire/ -- Arcadis, a global design and consultancy organization...

Project InnerSpace Among Top Five Highest Impact Non-Profits for 2026-2027

Independent charity evaluator, Giving Green, cites Project InnerSpace's leadership in accelerating next-generation geothermal energy worldwide as key driver of organizational impactBOSTON, Nov. 5, 2026...

Intensity Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update

New patient enrollment activities resumed in a limited number of U.S. sites in the soft tissue sarcoma Phase 3 INVINCIBLE-3 Study in the third...

HERVolution Publishes Translational Tumor Data Supporting HERV-K as an “Off-the-Shelf” Cancer Vaccine Target

Peer-reviewed study finds HERV-K antigen-coding sequences expressed in all 207 advanced non-small cell lung cancer tumors analyzed, and reports that lung cancer cell lines...

NORROY BIOSCIENCE Showcased 11 Research Presentations at EANM’ 26, Advancing Radiopharmaceutical Innovation and Global Ecosystem Collaboration

WUXI, China, Nov. 5, 2026 /PRNewswire/ -- NORROY BIOSCIENCE (NORROY), a late-stage clinical biotechnology company focused on innovative targeted radiopharmaceuticals, today announced that its...

Mondego Bio Initiates First-in-Human Study of MB‑388, an Oral Dual PTPN2/PTPN1 Inhibitor Designed to Overcome Resistance to Cancer Immunotherapy

Phase 1a study in healthy volunteers will assess safety, pharmacokinetics and pathway engagement; Phase 1b study in patients with advanced solid tumors planned to...

Aker Solutions receives letter of award for engineering scope on the Maydan Mahzam project in Qatar

OSLO, Norway, Nov. 5, 2026 /PRNewswire/ --  Aker Solutions has received a letter of award (LOA) from PTSC Mechanical and Construction Limited Company (PTSC M&C)...

OID 2026: Advancing Technology Partnerships to Power the Next-Gen Industrial City

HO CHI MINH CITY, Vietnam, Nov. 5, 2026 /PRNewswire/ -- Open Innovation Day 2026 (OID 2026), themed "Power the Next-Gen Industrial City," took place...

Telix Joins Thera4Care with TLX400-Tx to Accelerate Translation of Next Generation FAP-Targeting Theranostics

Thera4Care is an initiative aimed at establishing an integrated theranostics ecosystem to broaden patient access in EuropeTelix's fibroblast activation protein (FAP) targeting therapy candidate...

Ivonescimab Receives NMPA Priority Review for First-Line Biliary Tract Cancer

HONG KONG, Nov. 4, 2026 /PRNewswire/ -- Akeso, Inc. (HKEX: 9926.HK) today announced that ivonescimab in combination with chemotherapy for the first-line treatment of...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.